Director, Immunoassay Development

Vaxcyte is a clinical‑stage vaccine innovation company engineering high‑fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well‑defined, and Vaxcyte is set up to go the distance.

What we do is every bit as important as how we do it. Our work together is guided by four enduring core values:

• RETHINK CONVENTION:
  We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re‑innovate the way vaccines are delivered.
• AIM HIGH:
  We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind.
• LEAD WITH HEART:
  Everyone leads at Vaxcyte with a kindness‑first, inclusive approach to collaboration and vigorous debate that advances our business objectives.
• MODEL EXCELLENCE:
  The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making.

Vaxcyte is seeking an accomplished Director, Immunoassay Development to establish and lead a dedicated analytical function focused on immunoassay development for complex conjugated vaccines. This role will build and manage a laboratory‑based team responsible for developing, sustaining, and continuously improving potency‑ and antigenicity‑based immunoassays to support CMC development from preclinical through BLA‑stage programs and commercialization.

A key initial focus of this role will be stewardship of the VAX‑31 MSD immunoassay platform, which has been developed and advanced to Phase 3 through extensive internal leadership spanning clinical serology, GLP studies, and immunoassay development. The successful candidate will work in close partnership with current immunoassay leadership to ensure comprehensive knowledge transfer, continuity of scientific and execution excellence, and the long‑term robustness of the immunoassay strategy as accountability and responsibility intentionally transition into Analytical Development.

This is a hands‑on scientific leadership role anchored in CMC execution, GMP readiness, and lifecycle management of immunoassays supporting vaccine development, lot release and stability testing and commercialization.

• Establish and lead a new Immunoassay Development function within Analytical Development, defining scope, strategy, and operating model aligned with CMC and program needs.
• For VAX‑31, partner closely with current immunoassay leadership to learn and internalize the full development history, scientific rationale, and performance characteristics of the existing MSD‑based immunoassay platform.
• Serve as scientific steward for the VAX‑31 immunoassay, providing troubleshooting, root‑cause analysis, and technical problem‑solving support to Quality Control (QC) and Analytical Sciences and Technology (ASAT) teams.
• Support ASAT activities for VAX‑31, including qualification, lifecycle management, and change control of critical immunoassay reagents.
• Develop and execute immunoassay strategies to support potency, antigenicity, identity, and trace‑level impurity testing for conjugated vaccines across the pipeline.
• Lead the development and optimization of antigenicity‑ and potency‑based immunoassays suitable for late‑stage development and commercial use.
• Drive continuous improvement of existing immunoassays to enhance robustness, QC‑friendliness, throughput, and long‑term performance, even when methods are already deemed adequate.
• Build, mentor, and manage a team of laboratory scientists, fostering a cohesive, innovative, nimble, and high‑performing team culture grounded in scientific rigor and accountability.
• Provide critical scientific judgment and problem‑solving leadership when addressing complex, ambiguous, or conflicting technical challenges across programs.
• Manage immunoassay development activities across multiple projects, prioritizing resources, timelines,…